Afaf Abed

Hospital Avenue
Nedlands, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Prognostic Value of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lactate Dehydrogenase Level in Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Prognostic Value of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lactate Dehydrogenase Level in Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Journal: Cancer investigation

Published: November 13, 2025

HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with Chemotherapy.

HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with Chemotherapy.

Journal: Cancers

Published: August 13, 2024

Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.

Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.

Journal: ESMO open

Published: May 15, 2023

Association of Computed Tomography Measures of Muscle and Adipose Tissue and Progressive Changes throughout Treatment with Clinical Endpoints in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors.

Association of Computed Tomography Measures of Muscle and Adipose Tissue and Progressive Changes throughout Treatment with Clinical Endpoints in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors.

Journal: Cancers

Published: November 22, 2022

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab.

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab.

Journal: Translational lung cancer research

Published: April 20, 2022

Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients.

Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients.

Journal: Journal of cancer research and clinical oncology

Published: April 05, 2022

Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy.

Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 12, 2021

Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer.

Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer.

Journal: Translational lung cancer research

Published: October 06, 2021

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.

Journal: British journal of cancer

Published: March 08, 2021

Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy.

Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: October 27, 2020

Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Cells

Published: September 27, 2020

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 10, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026